Testicular cancer is one of the cancers most directly associated with PFOA exposure in scientific and regulatory literature. In 2023, the International Agency for Research on Cancer upgraded PFOA's classification to Group 1, carcinogenic to humans, with testicular cancer identified as one of the primary cancer sites driving that determination.
Claim ApplicationPFAS compounds accumulate in the body after repeated exposure and persist in tissue for years. Research points to three converging biological pathways through which PFOA may drive testicular carcinogenesis:
The C8 Science Panel, which studied communities exposed to PFOA contamination from the Washington Works chemical plant, concluded there was a probable link between PFOA exposure and testicular cancer, one of only a small number of diseases to meet that standard. In occupational cohort studies of chemical plant workers, firefighters, and industrial PFAS exposure groups, higher PFOA exposure levels have repeatedly been found to increase testicular cancer rates.
Maritime workers encountered PFAS primarily through aqueous film-forming foam used in shipboard firefighting drills, fire suppression systems, and emergency response training. Cumulative exposure over a career at sea may represent a significant PFAS burden.
Testicular cancer is a diagnosis that often affects men in their most productive working years, and a diagnosis that is linked to occupational PFAS exposure can have serious financial and personal fallout beyond medical expenses alone. If you worked at sea and were repeatedly exposed to firefighting foam and you were diagnosed with kidney cancer, ELG Law can help you understand your legal options and determine if you qualify for a Jones Act claim.